X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $63,620.62 +1.59%
Ethereum $1,675.66 +1.27%
BNB $603.08 +1.42%
Optimism $0.10 +3.10%
Arbitrum $0.08 +3.60%
Solana $67.00 +2.81%
Polygon $0.22 +2.77%
Cosmos $2.02 +9.28%
Avalanche $6.66 +0.79%

Bitcoin $63,620.62 +1.59%
Ethereum $1,675.66 +1.27%
BNB $603.08 +1.42%
Optimism $0.10 +3.10%
Arbitrum $0.08 +3.60%
Solana $67.00 +2.81%
Polygon $0.22 +2.77%
Cosmos $2.02 +9.28%
Avalanche $6.66 +0.79%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed